Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In the last four decades, the discovery and development of glucagon-like peptide 1 receptor agonists (GLP- 1RAs) reshaped the landscape of diabetes and weight management
Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24:185187 Noland RC, Koves TR, Seiler SE, Lum H, Lust RM, Ilkayeva O, Stevens RD, Hegardt FG, Muoio DM (2009) Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control
If you live with type 1 diabetes, chances are you've heard about GLP-1 medications Ozempic, Wegovy, Mounjaro mostly in the context of weight loss or type 2 diabetes
doi: 10.1161/circresaha.118.313142 127 SofiF.CesariF.AbbateR.GensiniG
The concept is straightforward
GLP-1 receptor agonists like Ozempic and Wegovy are changing the game when it comes to diabetes and weight management
